In an ongoing quest to find how exactly amyloid b protein is made from the amyloid precursor protein, researchers led by David Kang at the University of California, San Diego, have made a big step in the right direction. In a study published recently in the Journal of Biological Chemistry, Kang's team found that Ran-binding protein 9, RanBP9, plays a role by conjugating with another protein to form a scaffold that initiates the enzymatic cleavage of APP to Ab. The role of RanBP9, says Kang, could make it a possible new therapeutic target for Alzheimer's disease.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.